Spots Global Cancer Trial Database for esophageal carcinoma
Every month we try and update this database with for esophageal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy | NCT02062632 | Esophageal Carc... Hypopharyngeal ... Laryngeal Carci... Lymphoma Mesothelioma Metastatic Mali... Metastatic Mali... Metastatic Mali... Non-Small Cell ... Sarcoma Small Cell Lung... Thymic Carcinom... Thymoma Thyroid Gland C... | Doxepin Hydroch... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer | NCT06067438 | Atrial Fibrilla... Esophageal Carc... | Amiodarone Hydr... Saline | 18 Years - | OHSU Knight Cancer Institute | |
| Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | NCT02355249 | Esophageal Carc... | MIE OE | 18 Years - 75 Years | ChineseAMS | |
| Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma | NCT01783158 | Squamous Cell C... | Esophagoscopy a... | 18 Years - 65 Years | University Hospital Ostrava | |
| Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) | NCT06231680 | Lung Cancer, No... Esophageal Carc... | Camrelizumab Thalidomide 50m... Thalidomide 100... Thalidomide 200... Chemotherapy | 18 Years - | Henan Cancer Hospital | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | NCT00733889 | Esophageal Carc... | cetuximab and c... | 18 Years - 70 Years | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | NCT05476380 | Esophageal Carc... | camrelizumab | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial | NCT05775939 | Lung Carcinoma Esophageal Carc... | Fludeoxyglucose... Positron Emissi... Computed Tomogr... Questionnaire A... | 18 Years - | Thomas Jefferson University | |
| Esophagogastrectomy Versus Extended Gastrectomy in AEG II | NCT02302118 | Carcinomas of t... | Esophagogastrec... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
| A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | NCT03013712 | Colon Cancer Esophageal Carc... Pancreatic Canc... Prostate Cancer Gastric Cancer Hepatic Carcino... | CAR-T cell immu... | 18 Years - 80 Years | First Affiliated Hospital of Chengdu Medical College | |
| Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. | NCT00590031 | Esophageal Carc... | Cisplatin Irinotecan External Beam R... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | NCT06354218 | Esophageal Carc... | Serplulimab | 75 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial | NCT02033213 | Esophageal Neop... | Restrictive gro... Liberal group | 18 Years - | Klinički Bolnički Centar Zagreb | |
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | NCT06172478 | Advanced Solid ... Melanoma Head and Neck C... Gastric Cancer Ovarian Carcino... Cervical Cancer Endometrial Can... Bladder Cancer Esophageal Canc... Pancreatic Carc... Prostate Cancer | HER3-DXd | 18 Years - | Daiichi Sankyo | |
| Clinical Study of Pan-cancer DNA Methylation Test in Plasma | NCT05685524 | Cancer | DNA methylation... | 18 Years - 80 Years | Wuhan Ammunition Life-tech Co., Ltd | |
| Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . | NCT04652180 | Esophageal Canc... Esophageal Carc... Postoperative C... | Esophagectomy | 18 Years - | Hospital Universitari de Bellvitge | |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers | NCT03948100 | Esophageal Carc... Lung Non-Small ... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Educational Int... Quality-of-Life... Questionnaire A... Yoga | 18 Years - | M.D. Anderson Cancer Center | |
| Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia | NCT01097304 | Barrett Esophag... Esophageal Carc... | Ursodiol Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma | NCT05996484 | Esophageal Carc... Neoadjuvant The... | Toripalimab Anlotinib hydro... Albumin paclita... Cisplatin | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University | |
| A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | NCT05780736 | Esophageal Carc... Gastroesophagea... | 18 Years - | Bristol-Myers Squibb | ||
| Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | NCT06048913 | Esophageal Carc... | Nimotuzumab Tigio Concurrent radi... | 70 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial | NCT00907543 | Esophageal Neop... | Preoperative tr... Postoperative t... | 18 Years - | Lawson Health Research Institute | |
| Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer | NCT01691625 | Esophageal Carc... | concurrent chem... Concurrent chem... | 18 Years - | Capital Medical University | |
| A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | NCT05780736 | Esophageal Carc... Gastroesophagea... | 18 Years - | Bristol-Myers Squibb | ||
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | NCT03507998 | Colorectal Aden... Gastric Adenoca... Pancreatic Aden... Bile Duct Carci... Hepatocellular ... Esophageal Carc... Gastrointestina... | CGX1321 | 18 Years - | Curegenix Inc. | |
| Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy | NCT03094351 | Esophageal Canc... Esophageal Carc... | esophagectomy esophagectomy | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG) | NCT01271322 | Adenocarcinomas... | neoadjuvant rad... | 18 Years - 75 Years | National Center for Tumor Diseases, Heidelberg | |
| HS-20093 in Patients With Advanced Esophageal Carcinoma and Other Advanced Solid Tumors | NCT06112704 | Advanced Solid ... | HS-20093 | 18 Years - | Hansoh BioMedical R&D Company | |
| HS-20093 in Patients With Advanced Esophageal Carcinoma and Other Advanced Solid Tumors | NCT06112704 | Advanced Solid ... | HS-20093 | 18 Years - | Hansoh BioMedical R&D Company | |
| Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy | NCT01544790 | Esophageal Carc... Esophageal Canc... | Esophagectomy | 18 Years - 75 Years | UMC Utrecht | |
| Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma | NCT05937438 | Esophageal Carc... | Immune Checkpoi... | 18 Years - 75 Years | Anhui Provincial Hospital | |
| The Study on the Mechanism of Radiotherapy-elicited Immune Response | NCT06393140 | Esophageal Carc... Radiotherapy | 18 Years - | Fudan University | ||
| Spray Cryotherapy for Esophageal Cancer (ICE-CANCER) | NCT01868139 | Esophageal Canc... | Liquid nitrogen... | 18 Years - | University of Maryland, Baltimore | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer | NCT06009705 | Esophageal Carc... | toripalimab | 65 Years - | Hebei Medical University Fourth Hospital | |
| The Study on the Mechanism of Radiotherapy-elicited Immune Response | NCT06393140 | Esophageal Carc... Radiotherapy | 18 Years - | Fudan University | ||
| Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma | NCT05937438 | Esophageal Carc... | Immune Checkpoi... | 18 Years - 75 Years | Anhui Provincial Hospital | |
| Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma | NCT00176800 | Esophageal Carc... | Tetrathiomolybd... Radiation Surgery | 18 Years - | University of Michigan Rogel Cancer Center | |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer | NCT06067438 | Atrial Fibrilla... Esophageal Carc... | Amiodarone Hydr... Saline | 18 Years - | OHSU Knight Cancer Institute | |
| Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program | NCT06265285 | Advanced Esopha... Advanced Renal ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Esophageal Carc... Gastroesophagea... Hepatocellular ... Locally Advance... Lung Non-Small ... Malignant Solid... Metastatic Colo... Metastatic Cuta... Metastatic Esop... Metastatic Head... Metastatic Urot... Recurrent Esoph... Recurrent Head ... Renal Cell Carc... Stage III Renal... Stage IV Colore... Stage IV Cutane... Stage IV Renal ... Unresectable Cu... Unresectable Es... Urothelial Carc... | Home Health Enc... Nivolumab Patient Monitor... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | NCT05476380 | Esophageal Carc... | camrelizumab | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy | NCT04517019 | Bronchial Carci... Esophageal Carc... Tumor of the Br... Head and Neck C... Pancreas Cancer Sarcoma Cervix Uteri Ca... | Fitness tracker... | 18 Years - | University Hospital Tuebingen | |
| HS-20093 in Patients With Advanced Esophageal Carcinoma and Other Advanced Solid Tumors | NCT06112704 | Advanced Solid ... | HS-20093 | 18 Years - | Hansoh BioMedical R&D Company | |
| Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer | NCT02527057 | Esophageal Carc... | DW-MRI | 18 Years - 75 Years | Hunan Province Tumor Hospital | |
| Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy . | NCT04652180 | Esophageal Canc... Esophageal Carc... Postoperative C... | Esophagectomy | 18 Years - | Hospital Universitari de Bellvitge | |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy | NCT00991094 | Breast Carcinom... Esophageal Carc... Genitourinary S... Head and Neck C... Hematopoietic a... Lung Carcinoma Malignant Centr... Malignant Diges... Malignant Solid... | Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma | NCT02120911 | Esophageal Carc... | Pertuzumab, tra... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | NCT02355249 | Esophageal Carc... | MIE OE | 18 Years - 75 Years | ChineseAMS | |
| PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial | NCT05775939 | Lung Carcinoma Esophageal Carc... | Fludeoxyglucose... Positron Emissi... Computed Tomogr... Questionnaire A... | 18 Years - | Thomas Jefferson University | |
| Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma | NCT01034683 | Esophageal Carc... | lobaplatin , 5-... | 18 Years - 65 Years | Taian Cancer Hospital | |
| Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy | NCT00636298 | Esophageal Carc... | Bevacizumab, ce... | 18 Years - | Emory University | |
| Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia | NCT01097304 | Barrett Esophag... Esophageal Carc... | Ursodiol Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma | NCT00642239 | Esophageal Carc... | placebo Sodium Glycidid... | 18 Years - 70 Years | Shandong Luye Pharmaceutical Co., Ltd. | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | NCT02465060 | Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ... | Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| The Study on the Mechanism of Radiotherapy-elicited Immune Response | NCT06393140 | Esophageal Carc... Radiotherapy | 18 Years - | Fudan University | ||
| Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer | NCT02965976 | Esophageal Carc... | Botulinum Toxin... Esophagectomy Quality-of-Life... | 18 Years - | Roswell Park Cancer Institute | |
| Induction Chemotherapy for Locally Advanced Esophageal Cancer | NCT03110926 | Esophageal Carc... | mFOLFOX6 Chemoradiation | 18 Years - | University of Rochester | |
| Minimally Residual of Esophageal Cancer 001 | NCT05952661 | Esophageal Carc... Minimal Residua... | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | ||
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | NCT00733889 | Esophageal Carc... | cetuximab and c... | 18 Years - 70 Years | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation | NCT05059444 | Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc... | Guardant Reveal | 18 Years - | Guardant Health, Inc. | |
| Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study | NCT03933449 | Esophageal Carc... Esophagogastric... | pembrolizumab paclitaxel docetaxel irinotecan | 18 Years - | Merck Sharp & Dohme LLC | |
| Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer | NCT01691625 | Esophageal Carc... | concurrent chem... Concurrent chem... | 18 Years - | Capital Medical University | |
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma | NCT03220009 | Cervical Carcin... Esophageal Carc... Mucosal Melanom... Mucosal Melanom... Oral Cavity Muc... Recurrent Melan... Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IV Oral C... Stage IV Vulvar... Stage IVA Oral ... Stage IVB Oral ... Stage IVC Oral ... Vaginal Carcino... | Conventional Su... Ipilimumab Laboratory Biom... Nivolumab Patient Observa... Radiation Thera... | 18 Years - | National Cancer Institute (NCI) | |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial | NCT05775939 | Lung Carcinoma Esophageal Carc... | Fludeoxyglucose... Positron Emissi... Computed Tomogr... Questionnaire A... | 18 Years - | Thomas Jefferson University | |
| Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer | NCT03099382 | Esophageal Carc... | camrelizumab Docetaxel Irinotecan | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Comparable Study of Different Radiation Dose in Esophageal Carcinoma | NCT01937208 | Esophageal Carc... | intensity modul... concurrent chem... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma | NCT01783158 | Squamous Cell C... | Esophagoscopy a... | 18 Years - 65 Years | University Hospital Ostrava | |
| KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method) | NCT05680077 | Esophageal Neop... | KCNA3 and OTOP2... | 40 Years - | Wuhan Ammunition Life-tech Co., Ltd | |
| A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | NCT00733889 | Esophageal Carc... | cetuximab and c... | 18 Years - 70 Years | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial | NCT00907543 | Esophageal Neop... | Preoperative tr... Postoperative t... | 18 Years - | Lawson Health Research Institute | |
| Clinical Study of Pan-cancer DNA Methylation Test in Plasma | NCT05685524 | Cancer | DNA methylation... | 18 Years - 80 Years | Wuhan Ammunition Life-tech Co., Ltd | |
| Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | NCT04147494 | Breast Carcinom... Colon Carcinoma Esophageal Carc... Gastric Carcino... Head and Neck C... Kidney Carcinom... Lung Carcinoma Ovarian Carcino... Pancreatic Carc... Solid Neoplasm Uterine Corpus ... | Computed Tomogr... Gallium Ga 68 F... Gallium Ga 68-l... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer | NCT06199895 | Pancreatic Aden... Cholangiocarcin... Lung Cancer Stomach Cancer Esophageal Carc... Breast Cancer | Paclitaxel Poly... | 18 Years - | Tongji Hospital | |
| Spray Cryotherapy for Esophageal Cancer (ICE-CANCER) | NCT01868139 | Esophageal Canc... | Liquid nitrogen... | 18 Years - | University of Maryland, Baltimore | |
| Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | NCT06048913 | Esophageal Carc... | Nimotuzumab Tigio Concurrent radi... | 70 Years - | The First Affiliated Hospital with Nanjing Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
